Four-year recurrence-free survival in metastatic uterine adenosarcoma with somatic BRCA2 mutation on olaparib therapy: A case report

Authors

KATIE FOUG
Kevin Reynolds
Shitanshu Uppal (ORCID: https://orcid.org/0000-0002-8329-6948)
Stephanie L. Skala (ORCID: https://orcid.org/0000-0002-5631-5381)
Jean Siedel (ORCID: https://orcid.org/0000-0002-2596-3634)
Erica Stien

Institutions

University of Michigan (US)
Michigan Medicine (US)

Publication Details

Journal: Gynecologic Oncology Reports
Published: 2025-03-20
DOI: https://doi.org/10.1016/j.gore.2025.101724
Primary Topic: Uterine Myomas and Treatments
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Four-year recurrence-free survival in metastatic uterine adenosarcoma with somatic BRCA2 mutation on olaparib therapy: A case report

KATIE FOUG, Kevin Reynolds, Shitanshu Uppal, Stephanie L. Skala et al.

Mar 20, 2025

Gynecologic Oncology Reports

Uterine Myomas and Treatments

article

Four-year recurrence-free survival in metastatic uterine adenosarcoma with somatic BRCA2 mutation on olaparib therapy: A case report

KATIE FOUG, Kevin Reynolds, Shitanshu Uppal, Stephanie L. Skala, Jean Siedel, Erica Stien

March 20, 2025article en

Abstract

No abstract available for this paper.

Gynecologic Oncology ReportsVol. 58

University of Michigan (US), Michigan Medicine (US)

Openalex Percentile: Top 93%

Uterine Myomas and Treatments

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Four-year recurrence-free survival in metastatic uterine adenosarcoma with somatic BRCA2 mutation on olaparib therapy: A case report — KATIE FOUG, Kevin Reynolds, et al. · Gynecologic Oncology Reports (2025) | TGRS Research Map | TGRS